Potential treatments for COVID-19 have been identified by researchers from the University of Edinburgh after the discovery of five genes associated with the most severe form of the disease.
These genes are involved in two molecular processes, antiviral immunity, and lung inflammation.
According to the new study published by the journal Nature on December 11, 2020, genetic evidence is second only to clinical trials as a way to tell which treatments will be effective in a disease.
Human Genetics Identify Potential COVID-19 Treatments
USA Authorizes First COVID-19 Vaccine
The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) for a vaccine for the prevention of COVID-19) in individuals 16 years of age and older.
This EUA enables the experimental Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) to be distributed effectively in the USA.